UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

POLYMORPHISM OF BOVINE MHC CLASS II GENES. JOINT REPORT OF THE FIFTH INTERNATIONAL BOVINE LYMPHOCYTE ANTIGEN (BOLA) WORKSHOP, INTERLAKEN, SWITZERLAND, 1 AUGUST 1992

European journal of immunogenetics, 1994-08, Vol.21 (4), p.259-289

1994

Volltextzugriff (PDF)

POLYMORPHISM OF BOVINE MHC CLASS I GENES. JOINT REPORT OF THE FIFTH INTERNATIONAL BOVINE LYMPHOCYTE ANTIGEN (BoLA) WORKSHOP, INTERLAKEN, SWITZERLAND, 1 AUGUST 1992

European journal of immunogenetics, 1994-08, Vol.21 (4), p.239-258

1994

Volltextzugriff (PDF)

Joint Report of the Fourth International Bovine Lymphocyte Antigen (BoLA) Workshop, East Lansing, Michigan, USA, 25 August 1990

Animal genetics, 1991-12, Vol.22 (6), p.477-496

1991

Volltextzugriff (PDF)

Production of alloantibodies against bovine B-lymphocyte antigens

Animal genetics, 1991-10, Vol.22 (5), p.399-406

1991

Volltextzugriff (PDF)

Differential Adhesion Molecule Expression on Porcine Mononuclear Cell Populations

Scandinavian journal of immunology, 1998-05, Vol.47 (5), p.487-495

1998

Volltextzugriff (PDF)

Cross reactivity of anti-human CD monoclonal antibodies with porcine leukocytes

Veterinary immunology and immunopathology, 1996-11, Vol.54 (1), p.113-113

1996

Volltextzugriff (PDF)

Lack of association of bovine MHC class I alleles with carcass and reproductive traits

Animal genetics, 1996-12, Vol.27 (6), p.429-431

1996

Volltextzugriff (PDF)

Possible association between a serologically detected haplotype of the bovine Major Histocompatibility Complex and subclinical mastitis

Journal of animal breeding and genetics (1986), 1994-01, Vol.111 (1-6), p.152-161

1994

Volltextzugriff (PDF)

Associations of serologically defined BoLA class I alleles with milk production traits in three Swiss cattle breeds

Livestock production science, 1996-05, Vol.45 (2), p.163-169

1996

Volltextzugriff (PDF)

Polymorphiosm of bovine MHC class I genes. Joint report of the Fifth International bovine lymphocyte antigen (BoLA) workshop, interlaken, Switzerland, 1 August 1992

European journal of immunogenetics, 1994, Vol.21 (4), p.239-258

1994

Volltextzugriff (PDF)

Phenology of feeding preference in post‐diapause Baltimore checkerspot (Euphydryas phaeton) caterpillars

Ecological entomology, 2021-04, Vol.46 (2), p.310-318

2021

Volltextzugriff (PDF)

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes

Arthritis & rheumatology (Hoboken, N.J.), 2019-03, Vol.71 (3), p.411-419

2019

Volltextzugriff (PDF)

POS0388 INTEGRATED SOLUBLE PROTEOMICS AND AUTOREACTOMICS: PREDICTING RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.290-290

2024

Volltextzugriff (PDF)

Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies

Frontiers in immunology, 2021-05, Vol.12, p.635072-635072

2021

Volltextzugriff (PDF)

POS0341 DECONVOLUTION OF TRANSCRIPTOMICS CHANGES IN DEUCRAVACITINIB-TREATED SUBJECTS REVEALS NOVEL MECHANISTIC EFFECTS OF TYK2 INHIBITION IN LUPUS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.266-267

2024

Volltextzugriff (PDF)

AB0521 IDENTIFICATION OF AN INTERFERON 5-GENE SIGNATURE SCORE AS A PHARMACODYNAMIC AND POTENTIAL PREDICTIVE BIOMARKER FOR DEUCRAVACITINIB TREATMENT IN A PHASE 2 TRIAL IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1456-1456

2023

Volltextzugriff (PDF)

Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype

Frontiers in immunology, 2024, Vol.15, p.1339250-1339250

2024

Volltextzugriff (PDF)

1007 Voclosporin for lupus nephritis: assessment of long-term safety and efficacy including renal outcome over three years of treatment in the phase 3 AURORA 1 and AURORA 2 studies

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A85-A85

2024

Volltextzugriff (PDF)

Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model

PLoS neglected tropical diseases, 2018-01, Vol.12 (1), p.e0006116-e0006116

2018

Volltextzugriff (PDF)

FAPα-TARGETED IMMUNOTHERAPY WITH SIBROTUZUMAB AND HIGH AFFINITY FC-RECEPTOR EXPRESSING NK92 CELLS: A PROMISING APPROACH TO REVERSE FIBROSIS

Cytotherapy (Oxford, England), 2024-06, Vol.26 (6), p.S177-S177

2024

Volltextzugriff (PDF)

POS1066 SINGLE-CELL MULTI-OMIC EVALUATION OF DIFFERENCES IN T CELL POPULATIONS IN PROGRESSION OF SLE

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.944-944

2024

Volltextzugriff (PDF)

POS1154 PRE-TREATMENT DIFFERENTIALLY EXPRESSED METAGENES CHARACTERIZE SYSTEMIC LUPUS PATIENTS WHO SUBSEQUENTLY ACHIEVE CLINICAL RESPONSE TO BELIMUMAB

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.908-909

2023

Volltextzugriff (PDF)

POS0296 GENE EXPRESSION IN SLE PATIENTS, DOMINATED BY UNIQUE B CELL PROFILES, DISTINGUISHES THOSE WITH CLINICAL IMPROVEMENT FROM ABATACEPT

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.390-390

2023

Volltextzugriff (PDF)

POS1155 IMPACT OF HYDROXYCHLOROQUINE ON INTERFERON PATHWAY EXPRESSION OF SLE PHENOTYPIC SUBSETS IN THE ABSENCE OF BACKGROUND MEDICATIONS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.909-909

2023

Volltextzugriff (PDF)

AB0530 DESIGN OF 2 PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, GLOBAL TRIALS OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1463-1463

2023

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(50)
Buchkapitel
(1)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(23)
Lupus
(18)
Systemic Lupus Erythematosus
(15)
Immunology
(11)
Animals
(10)
Clinical Trials
(10)
Patients
(10)
Autoantibodies
(8)
Biological And Medical Sciences
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Humans
(7)
Rheumatology
(6)
Antigens
(5)
Autoimmune Diseases
(5)
Cattle - Immunology
(5)
Female
(5)
Fundamental Immunology
(5)
Gene Expression
(5)
Placebos
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

POLYMORPHISM OF BOVINE MHC CLASS II GENES. JOINT REPORT OF THE FIFTH INTERNATIONAL BOVINE LYMPHOCYTE ANTIGEN (BOLA) WORKSHOP, INTERLAKEN, SWITZERLAND, 1 AUGUST 1992

POLYMORPHISM OF BOVINE MHC CLASS I GENES. JOINT REPORT OF THE FIFTH INTERNATIONAL BOVINE LYMPHOCYTE ANTIGEN (BoLA) WORKSHOP, INTERLAKEN, SWITZERLAND, 1 AUGUST 1992

Joint Report of the Fourth International Bovine Lymphocyte Antigen (BoLA) Workshop, East Lansing, Michigan, USA, 25 August 1990

Production of alloantibodies against bovine B-lymphocyte antigens

Differential Adhesion Molecule Expression on Porcine Mononuclear Cell Populations

Cross reactivity of anti-human CD monoclonal antibodies with porcine leukocytes

Lack of association of bovine MHC class I alleles with carcass and reproductive traits

Possible association between a serologically detected haplotype of the bovine Major Histocompatibility Complex and subclinical mastitis

Associations of serologically defined BoLA class I alleles with milk production traits in three Swiss cattle breeds

Polymorphiosm of bovine MHC class I genes. Joint report of the Fifth International bovine lymphocyte antigen (BoLA) workshop, interlaken, Switzerland, 1 August 1992

Phenology of feeding preference in post‐diapause Baltimore checkerspot (Euphydryas phaeton) caterpillars

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes

POS0388 INTEGRATED SOLUBLE PROTEOMICS AND AUTOREACTOMICS: PREDICTING RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS

Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies

POS0341 DECONVOLUTION OF TRANSCRIPTOMICS CHANGES IN DEUCRAVACITINIB-TREATED SUBJECTS REVEALS NOVEL MECHANISTIC EFFECTS OF TYK2 INHIBITION IN LUPUS

AB0521 IDENTIFICATION OF AN INTERFERON 5-GENE SIGNATURE SCORE AS A PHARMACODYNAMIC AND POTENTIAL PREDICTIVE BIOMARKER FOR DEUCRAVACITINIB TREATMENT IN A PHASE 2 TRIAL IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype

1007 Voclosporin for lupus nephritis: assessment of long-term safety and efficacy including renal outcome over three years of treatment in the phase 3 AURORA 1 and AURORA 2 studies

Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model

FAPα-TARGETED IMMUNOTHERAPY WITH SIBROTUZUMAB AND HIGH AFFINITY FC-RECEPTOR EXPRESSING NK92 CELLS: A PROMISING APPROACH TO REVERSE FIBROSIS

POS1066 SINGLE-CELL MULTI-OMIC EVALUATION OF DIFFERENCES IN T CELL POPULATIONS IN PROGRESSION OF SLE

POS1154 PRE-TREATMENT DIFFERENTIALLY EXPRESSED METAGENES CHARACTERIZE SYSTEMIC LUPUS PATIENTS WHO SUBSEQUENTLY ACHIEVE CLINICAL RESPONSE TO BELIMUMAB

POS0296 GENE EXPRESSION IN SLE PATIENTS, DOMINATED BY UNIQUE B CELL PROFILES, DISTINGUISHES THOSE WITH CLINICAL IMPROVEMENT FROM ABATACEPT

POS1155 IMPACT OF HYDROXYCHLOROQUINE ON INTERFERON PATHWAY EXPRESSION OF SLE PHENOTYPIC SUBSETS IN THE ABSENCE OF BACKGROUND MEDICATIONS

AB0530 DESIGN OF 2 PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, GLOBAL TRIALS OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS

Aktive Filter

Suchergebnisse filtern